GlassScriptPhysician profile
Marian L Bertotti
NPI 1639174774
$958.77
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $12.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $289.07 | 2019 | |
| Amgen INC. | $171.83 | 2019 | |
| Allergan, INC. | $127.17 | 2019 | |
| Lilly USA, LLC | $66.03 | 2019 | |
| Pfizer INC. | $59.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.78 | 2019 | |
| Glaxosmithkline, LLC. | $39.23 | 2019 | |
| Janssen Pharmaceuticals, INC | $35.56 | 2019 | |
| Novo Nordisk INC | $27.18 | 2019 | |
| Boston Scientific Corporation | $13.77 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.57 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.54 | 2019 | |
| Duchesnay USA Incorporated | $12.09 | 2019 | |
| Bausch Health US, LLC | $12.05 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marian Bertotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.